Agoracom Blog
«
»

@Novamind_Inc $NM.ca $NVMDF Weekly Roundup $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 11:32 AM on Saturday, February 27th, 2021

A weekly summary of Novamind news and media

FEATURES February 24, 2021

Expanding Access and Feeding Demand for New Treatment Options

Yaron Conforti spoke to CSE TV about how Novamind is creating access points to alternative mental health treatments.

View all media

Novamind to Present at Benzinga Conference

February 23, 2021

Novamind Fast Tracked for Inclusion in Horizons Psychedelic ETF

February 22, 2021

View all press releases

Follow @novamind_inc on Instagram

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca

Tags: , , , , , ,

This entry was posted on Saturday, February 27th, 2021 at 11:32 am and is filed under Novamind Inc.. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.